Xtant Medical Holdings, Inc. - Common Stock (XTNT)

CUSIP: 98420P308

Q1 2026 13F Holders as of 31 Mar 2026

Type / Class
Equity / Common Stock
Shares outstanding
140,036,400
Total 13F shares
80,736,006
Share change
-668,739
Total reported value
$45,051,748
Price per share
$0.56
Number of holders
34
Value change
-$391,346
Number of buys
10
Number of sells
12

Security key

98420P308

Report period

Q1 2026

Institutions

34

Top holders

10

Top shareholders of XTNT - Xtant Medical Holdings, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Nantahala Capital Management, LLC
13F 13D/G 3/4/5
Company · 10%+ Owner
49%
from 13D/G
68,394,000
$53,620,896 31 Dec 2025
Laurence W. Lytton
13D/G
LYTTON LAURENCE W
5.5%
7,702,002
$5,545,441 -$1,268,237 31 Dec 2025
Stavros G. Vizirgianakis
3/4/5
Director
5.4%
7,515,570
$5,786,988 15 Nov 2025
Jonn R. Beeson
3/4/5
Director
1.1%
1,532,891
$1,180,325 15 Nov 2025
John K. Bakewell
3/4/5
Director
0.65%
914,116
$703,869 15 Nov 2025
Abhinav Jain
3/4/5
Director
0.11%
158,228
$121,835 15 Nov 2025
Tyler Lipschultz
3/4/5
Director
0.11%
158,228
$121,835 15 Nov 2025
AWM Investment Company, Inc.
13F
Company
4.7%
6,594,121
$5,169,791 31 Dec 2025
13F
VANGUARD GROUP INC
13F
Company
1.6%
2,272,591
$1,781,712 31 Dec 2025
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.66%
919,860
$721,170 31 Dec 2025
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.35%
491,949
$385,788 31 Dec 2025
13F
Crescent Grove Advisors, LLC
13F
Company
0.29%
412,024
$323,027 31 Dec 2025
13F
Hillsdale Investment Management Inc.
13F
Company
0.26%
362,200
$283,965 31 Dec 2025
13F
CITADEL ADVISORS LLC
13F
Company
0.21%
287,798
$225,634 31 Dec 2025
13F
NANO CAP NEW MILLENNIUM GROWTH FUND L P
13F
Company
0.2%
280,000
$219,520 31 Dec 2025
13F
ACADIAN ASSET MANAGEMENT LLC
13F
Company
0.14%
194,062
$149,000 31 Dec 2025
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.14%
190,846
$149,623 31 Dec 2025
13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC
13F
Company
0.12%
164,100
$128,654 31 Dec 2025
13F
BlackRock, Inc.
13F
Company
0.08%
115,782
$90,773 31 Dec 2025
13F
Mink Brook Asset Management LLC
13F
Company
0.08%
109,466
$85,821 31 Dec 2025
13F
WIREGRASS INVESTMENT MANAGEMENT LLC
13F
Company
0.07%
103,000
$80,752 31 Dec 2025
13F
Tradition Wealth Management, LLC
13F
Company
0.07%
100,297
$78,633 31 Dec 2025
13F
Private Advisor Group, LLC
13F
Company
0.06%
85,000
$66,640 31 Dec 2025
13F
TWO SIGMA SECURITIES, LLC
13F
Company
0.06%
77,350
$60,642 31 Dec 2025
13F
NORTHERN TRUST CORP
13F
Company
0.04%
57,464
$45,052 31 Dec 2025
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.03%
36,158
$28,348 31 Dec 2025
13F
STATE STREET CORP
13F
Company
0.02%
31,266
$24,513 31 Dec 2025
13F
PRUDENTIAL FINANCIAL INC
13F
Company
0.02%
23,400
$18,346 31 Dec 2025
13F
LAZARD ASSET MANAGEMENT LLC
13F
Company
0.02%
22,720
$17,812 31 Dec 2025
13F
Virtu Financial LLC
13F
Company
0.01%
20,146
$16,000 31 Dec 2025
13F
Kestra Advisory Services, LLC
13F
Company
0.01%
20,000
$15,680 31 Dec 2025
13F
JANE STREET GROUP, LLC
13F
Company
0.01%
19,206
$15,058 31 Dec 2025
13F
Equitable Holdings, Inc.
13F
Company
0.01%
11,450
$8,977 31 Dec 2025
13F
Tower Research Capital LLC (TRC)
13F
Company
0%
4,616
$3,619 31 Dec 2025
13F
MassMutual Private Wealth & Trust, FSB
13F
Company
0%
2,000
$1,568 31 Dec 2025
13F
MORGAN STANLEY
13F
Company
0%
1,125
$882 31 Dec 2025
13F
BANK OF AMERICA CORP /DE/
13F
Company
0%
428
$336 31 Dec 2025
13F
VALLEY WEALTH MANAGERS, INC.
13F
Company
0%
298
$234 31 Dec 2025
13F
Cornerstone Planning Group LLC
13F
Company
0%
12
$7 31 Dec 2025
13F
UBS Group AG
13F
Company
0%
8
$6 31 Dec 2025
13F
SBI Securities Co., Ltd.
13F
Company
0%
2
$2 31 Dec 2025
13F
Matthew Rizzo
3/4/5
Director, 10%+ Owner
class O/S missing
17,325,033
$10,552,677 15 Aug 2022
Michael Eggenberg
3/4/5
Director, 10%+ Owner
class O/S missing
17,325,033
$10,552,677 15 Aug 2022
Sean E. Browne
3/4/5
President and CEO, Director
mixed-class rows
3,365,148
mixed-class rows
$1,982,960 15 Nov 2025
Kevin D. Brandt
3/4/5
Chief Commercial Officer
class O/S missing
943,736
$566,242 15 Aug 2024
Scott C. Neils
3/4/5
CFO and Assistant Secretary
mixed-class rows
1,369,963
mixed-class rows
$548,197 15 Jan 2026
Robert McNamara
3/4/5
Director
class O/S missing
754,151
$452,491 15 Aug 2024
Mark A. Schallenberger
3/4/5
Chief Operating Officer
mixed-class rows
1,247,663
mixed-class rows
$384,631 15 Feb 2026
Jeffrey J. Peters
3/4/5
Director
class O/S missing
448,546
$273,209 15 Aug 2022
D. Mitchell Keller
3/4/5
Director
class O/S missing
353,124
$211,874 15 Aug 2024

Institutional Holders of Xtant Medical Holdings, Inc. - Common Stock (XTNT) as of Q1 2026

As of 31 Mar 2026, Xtant Medical Holdings, Inc. - Common Stock (XTNT) was held by 34 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 80,736,006 shares. The largest 10 holders included Nantahala Capital Management, LLC, AWM Investment Company, Inc., VANGUARD CAPITAL MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, Crescent Grove Advisors, LLC, Hillsdale Investment Management Inc., NANO CAP NEW MILLENNIUM GROWTH FUND L P, VANGUARD FIDUCIARY TRUST CO, and ACADIAN ASSET MANAGEMENT LLC. This page lists 34 institutional shareholders reporting positions in this security for the Q1 2026 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q1 2026 vs Q4 2025 Across Filers

Q4 2025 holders
35
Q1 2026 holders
34
Holder diff
-1
Investor Q4 2025 Shares Q1 2026 Shares Share Diff Share Chg % Q4 2025 Value $ Q1 2026 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .